Dynavax Technologies Corporation (NASDAQ:DVAX) announced that the Company and AstraZeneca signed an amendment to their existing Research Collaboration and License Agreement under which, based …
While the iShares Nasdaq Biotechnology (IBB) fell nearly 4% today, biotech companies Dynavax Technologies Corporation (NASDAQ:DVAX) and Uniqure NV (NASDAQ:QURE) climbed sharply higher after presenting …
Chipotle Mexican Grill, Inc. (NYSE:CMG) is falling close to 5% after the company disclosed in a SEC filing that it received a subpoena …
Dynavax Technologies Corporation (NASDAQ:DVAX) reported preliminary top-line results from HBV-23, a Phase 3 trial of the safety and immunogenicity of its investigational hepatitis B …
Dynavax Technologies Corporation (NASDAQ:DVAX) reported financial results for the third quarter endedSeptember 30, 2015. The Company had $220.
William Blair analysts John Sonnier and Y Katherine Xu issued a note to investors on August 26 highlighting their best investment ideas in …
Dynavax Technologies Corporation (NASDAQ:DVAX) reported financial results for the second quarter ended June 30, 2015. The Company had $93.
Dynavax Technologies Corporation (NASDAQ:DVAX) announced the completion of an underwritten public offering of 5,227,273 shares of its common stock, including 681,818 shares sold pursuant …
Dynavax Technologies Corporation (NASDAQ:DVAX) announced the pricing of a previously announced underwritten public offering of 4,545,455 shares of its common stock, offered at a …
Dynavax Technologies Corporation (NASDAQ:DVAX) announced that it intends to offer and sell shares of its common stock, subject to market and other conditions, in …
